PAT and QbD
With the PAT (Process Analytical Technology) and QbD (Quality by Design) initiatives, the FDA aims to bring about an increase in efficiency in pharmaceutical production, including a trend away from final checks towards real-time process analysis and control.
Fast process monitoring
ProcessLab, a robust and easy-to-use system that is installed directly within the process, makes it possible to carry out not only the release analyses, but also the analysis of intermediate products. The sample is brought to the ProcessLab and the analysis is started with a single push of a button.
Just a few minutes after sampling, the relevant process information is available to a LIMS or the master display. The process conditions can be rapidly and efficiently altered according to the preset conditions
